Social Forces to Improve Statin Adherence (Study A)
Completed · Not applicable
Conditions studied: Medication Adherence, High Blood Pressure, Diabetes
In brief
To assess the effectiveness of reporting statin adherence patterns to a Medication Adherence Partner (MAP) in improving the outcome of statin adherence versus usual care as measured by an electronic pill bottle. Hypothesis: Subjects with a MAP receiving daily adherence feedback will have the highest statin adherence of any arm, as measured by pill bottle data.
Key facts
- Study ID
- NCT02018809
- Run by
- University of Pennsylvania
- People needed
- 200
- Starts
- 2014-01-01
- Expected to finish
- 2015-01-01
- Last updated by the study team
- 2017-09-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- The subject is Humana insured
- The subject is an English speaking adult
- Age range ≥18 years
- The subject has diagnosis with diabetes for ≥12 months
- The subject has an MPR <70% to a statin medication
- Subject denies side-effects to their statin medication
- The subject identified a person who agreed to serve as their MAP
You may not qualify if…
- The subject is <18 years old
- The subject is considered part of a vulnerable population (is a prisoner, a cognitively impaired person, or a pregnant woman)
- On statin combination medication
- The subject does not identify an individual who agrees to serve as their MAP
- The subject reports a clinically important side effect to the statin medication or active liver disease:
Where it is running
- University of Pennsylvania Perelman School of Medicine — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.